EQL Pharma AB (publ) (STO:EQL)
Sweden flag Sweden · Delayed Price · Currency is SEK
20.60
+0.05 (0.24%)
At close: Jul 24, 2026

EQL Pharma AB Financials Overview

Millions SEK. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
432.66432.66373.52264.17259.91409.75
Revenue Growth
15.83%15.83%41.39%1.64%-36.57%128.73%
Gross Profit
162.84162.84155.95115.05115.8595.73
Operating Income
48.6948.6967.3732.6241.3438.84
Net Income
12.5412.5443.1222.7130.9231.55
Earnings Per Share
0.420.421.440.761.041.09
EPS Growth
-70.83%-70.83%89.47%-26.92%-4.59%202.78%

Revenue by Geography

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Sweden
144.66144.66164.83145.28162.77365.22
Other Scandinavia
196.01196.01----
Other Europe
91.1691.1655.7428.249.72-
Outside Europe
0.840.840.55---
Denmark
--106.4857.2168.9-
Norway
--32.1626.5515.83-
Finland
--13.756.892.69-
Total
432.66432.66373.52264.17259.91409.75

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
86.7686.7682.420.4744.4341.2
Total Debt
448.4448.4455.71120.0966.6276.1
Net Cash (Debt)
-361.64-361.64-373.31-99.63-22.19-34.9
Net Cash Growth
------
Net Cash Per Share
-11.99-11.99-12.49-3.34-0.75-1.18

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
28.3628.36-24.65-11.4427.6241.83
Capital Expenditures
-5.44-5.44-6.13-0.93-0.46-0.63
Free Cash Flow
22.9222.92-30.78-12.3627.1641.2
Free Cash Flow Growth
-----34.08%-31.39%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
37.64%37.64%41.75%43.55%44.57%23.36%
Operating Margin
11.25%11.25%18.04%12.35%15.90%9.48%
Pretax Margin
4.21%4.21%14.55%10.83%14.99%8.78%
Profit Margin
2.90%2.90%11.54%8.59%11.90%7.70%
FCF Margin
5.30%5.30%-8.24%-4.68%10.45%10.06%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
49.05129.5249.31---
Forward PE
25.3529.1731.2116.99--
P/FCF Ratio
26.5470.10----
PS Ratio
1.413.715.52---